Stay updated with breaking news from Nyse vor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vor Biopharma (NYSE:VOR – Get Free Report)‘s stock had its “outperform” rating reiterated by Wedbush in a report issued on Thursday, Benzinga reports. They presently have a $11.00 price objective on the stock. Wedbush’s target price suggests a potential upside of 378.26% from the company’s previous close. Vor Biopharma Trading Down 0.9 % VOR opened […] ....
Vor Biopharma Inc. (NYSE:VOR – Get Free Report) has been given a consensus rating of “Buy” by the seven brokerages that are presently covering the firm, Marketbeat reports. Seven equities research analysts have rated the stock with a buy rating. The average 1 year price objective among analysts that have covered the stock in the […] ....
Shares of Vor Biopharma Inc. (NYSE:VOR – Get Free Report) have received a consensus recommendation of “Buy” from the seven analysts that are presently covering the stock, Marketbeat Ratings reports. Seven research analysts have rated the stock with a buy rating. The average twelve-month price target among brokerages that have covered the stock in the […] ....
Artal Group S.A. trimmed its position in Vor Biopharma Inc. (NYSE:VOR – Free Report) by 3.8% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,688,015 shares of the company’s stock after selling 104,790 shares during the period. Artal Group S.A. owned approximately […] ....
Shares of Vor Biopharma Inc. (NYSE:VOR – Get Free Report) have been assigned an average recommendation of “Buy” from the eight brokerages that are presently covering the company, Marketbeat Ratings reports. Eight research analysts have rated the stock with a buy rating. The average 12 month price target among analysts that have issued ratings on […] ....